This article was originally published in The Rose Sheet
Executive SummaryYves Saint Laurent fragrance and cosmetics sales increased 5.7% on constant currency basis for fiscal second quarter ended July 31, Gucci announces in 1sales and earnings report Sept. 26. Sales were fueled by strong growth of Opium, which saw a 23.6% increase in sales during the period, company adds. Despite strength of Yves Saint Laurent, YSL Beauté consolidated sales fell 3.8% during the quarter to $104.4 mil. (€1=$.98). Beauty division still on track to achieve high single-digit revenue growth and operating margin before goodwill and trademark amortization of approximately 7%, Gucci maintains...
You may also be interested in...
Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.
First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.
Brands unfairly attacked by powerful influencers could raise the subject with the US Federal Trade Commission, which is asking for comments on its “Endorsement Guides."